Primary observations of EVO ICL implantation for high myopia with concave iris.

"Declarations Ethics approval and consent to participateThe participants were fully informed of the details and potential risks of the procedure and provided written informed consent. This study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Eye & ENT Hospital, Fudan University, China (No. 2016038). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by Provincial High-level University Construction Project (Grant No. DGF501035/006/003), National Natural Science Foundation of China (Grant No. 81770955), Research Project Grant of Shanghai Municipal Health Commission (Grant No. 202040285), Project of Shanghai Science and Technology (Grant No. 20410710100), Joint Research Project of New Frontier Technology in Municipal Hospitals (Grant No. SHDC12018103), Clinical Research Plan of SHDC (Grant No. SHDC2020CR1043B), Project of Shanghai Xuhui District Science and Technology (Grant No. 2020- 015). The funding agencies had no role in study design, data collection and analysis, interpretation of data, or writing the manuscript."